Ipca Laboratories shares fall 2.01%; annual net profit declines despite revenue growth

• Ipca Laboratories shares fell 2.01% to Rs 1,436.50 on Monday.
• Annual revenue increased from Rs 5,419.99 crore in 2021 to Rs 8,939.59 crore in 2025.
• Annual net profit decreased from Rs 1,148.84 crore in 2021 to Rs 787.53 crore in 2025, with EPS also declining.
• US FDA inspected the company's Tarapur API manufacturing facility on December 5, 2025.
• The company regularly declared dividends, with the latest final dividend of Rs 2.00 per share declared on May 29, 2025.

Why It Matters: Ipca Laboratories' stock shows mixed sentiment due to financial trends and regulatory checks.